Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn A Gibson

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritisIsabel Castrejón, Kathryn A Gibson, Theodore Pincus
Rheumatology (Oxford, England)|March 29, 2025
Elevated DAS28, CDAI, RAPID3, and 5/7 RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQTheodore Pincus, Tengfei Li, Kathryn A Gibson
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Update on methotrexate as the anchor drug for rheumatoid arthritisTheodore Pincus, Kathryn A Gibson, Isabel Castrejón
ACR Open Rheumatology|May 20, 2025
Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?Theodore Pincus, Tengfei Li, Kathryn A Gibson
Clinical and Experimental Rheumatology|October 3, 2017
Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritisJacquelin R Chua, Kathryn A Gibson, Theodore Pincus
The Journal of Rheumatology|September 3, 2019
Fibromyalgia Assessment Screening Tool: Clues to Fibromyalgia on a Multidimensional Health Assessment Questionnaire for Routine CareKathryn A Gibson, Isabel Castrejon, Joseph Descallar, et al.
Seminars in Arthritis and Rheumatism|September 1, 2024
Can a simple 0-10 RheuMetric physician estimate of inflammatory activity (DOCINF) depict a detailed swollen joint count (SJC) as accurately as a DAS28 or CDAI in patients with rheumatoid arthritis?Theodore Pincus, Tengfei Li, Rahel Hunter, et al.
JMIR Cancer|September 21, 2021
Computer-Based Decision Tools for Shared Therapeutic Decision-making in Oncology: Systematic ReviewAlan Yung, Judy Kay, Philip Beale, et al.
Seminars in Arthritis and Rheumatism|February 15, 2024
PROMIS-29 in rheumatoid arthritis patients who screen positive or negative for fibromyalgia on MDHAQ FAST4 (fibromyalgia assessment screening tool) or 2011 fibromyalgia criteriaKathryn A Gibson, Robert M Kaplan, Theodore Pincus, et al.
ACR Open Rheumatology|August 23, 2023
RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference MeasuresNicholas Rodwell, Geraldine Hassett, Paul Bird, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritisIsabel Castrejón, Kathryn A Gibson, Theodore Pincus
Rheumatology (Oxford, England)|March 29, 2025
Elevated DAS28, CDAI, RAPID3, and 5/7 RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQTheodore Pincus, Tengfei Li, Kathryn A Gibson
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Update on methotrexate as the anchor drug for rheumatoid arthritisTheodore Pincus, Kathryn A Gibson, Isabel Castrejón
ACR Open Rheumatology|May 20, 2025
Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?Theodore Pincus, Tengfei Li, Kathryn A Gibson
Clinical and Experimental Rheumatology|October 3, 2017
Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritisJacquelin R Chua, Kathryn A Gibson, Theodore Pincus
The Journal of Rheumatology|September 3, 2019
Fibromyalgia Assessment Screening Tool: Clues to Fibromyalgia on a Multidimensional Health Assessment Questionnaire for Routine CareKathryn A Gibson, Isabel Castrejon, Joseph Descallar, et al.
Seminars in Arthritis and Rheumatism|September 1, 2024
Can a simple 0-10 RheuMetric physician estimate of inflammatory activity (DOCINF) depict a detailed swollen joint count (SJC) as accurately as a DAS28 or CDAI in patients with rheumatoid arthritis?Theodore Pincus, Tengfei Li, Rahel Hunter, et al.
JMIR Cancer|September 21, 2021
Computer-Based Decision Tools for Shared Therapeutic Decision-making in Oncology: Systematic ReviewAlan Yung, Judy Kay, Philip Beale, et al.
Seminars in Arthritis and Rheumatism|February 15, 2024
PROMIS-29 in rheumatoid arthritis patients who screen positive or negative for fibromyalgia on MDHAQ FAST4 (fibromyalgia assessment screening tool) or 2011 fibromyalgia criteriaKathryn A Gibson, Robert M Kaplan, Theodore Pincus, et al.
ACR Open Rheumatology|August 23, 2023
RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference MeasuresNicholas Rodwell, Geraldine Hassett, Paul Bird, et al.
Pageof 3